Хайлтын үр дүнгүүд - Mark A. Ator

  • 8-н 1 - 8 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    Protein control of prosthetic heme reactivity. Reaction of substrates with the heme edge of horseradish peroxidase.

    Protein control of prosthetic heme reactivity. Reaction of substrates with the heme edge of horseradish peroxidase. -н Mark A. Ator, P.R. Ortiz de Montellano

    Хэвлэсэн 1987
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis

    A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis -н Kristine L. Stump, Lily Lu, Paweł Dobrzański, Cynthia Serdikoff, Diane E. Gingrich, Benjamin J. Dugan, Thelma S. Angeles, Mark S. Albom, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Matthew M. Seavey

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2

    Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2 -н Lily Lu, Kristine L. Stump, Nate H. Wallace, Paweł Dobrzański, Cynthia Serdikoff, Diane E. Gingrich, Benjamin J. Dugan, Thelma S. Angeles, Mark S. Albom, Jennifer Mason, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Matthew M. Seavey

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers

    CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers -н Mangeng Cheng, Matthew R. Quail, Diane E. Gingrich, Gregory R. Ott, Lihui Lü, Weihua Wan, Mark S. Albom, Thelma S. Angeles, Lisa D. Aimone, Flavio Cristofani, Rodolfo Machiorlatti, Cristina Abele, Mark A. Ator, Bruce D. Dorsey, Giorgio Inghirami, Bruce Ruggeri

    Хэвлэсэн 2011
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor

    Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor -н Joel Kaye, Victor Piryatinsky, Tal Birnberg, Tal Hingaly, Emanuel Raymond, Rina Kashi, Einat Amit‐Romach, Ignacio Caballero, Fadi Towfic, Mark A. Ator, Efrat Rubinstein, Daphna Laifenfeld, Aric Orbach, Doron Shinar, Yael Marantz, Iris Grossman, Volker Knappertz, Michael R. Hayden, Ralph Laufer

    Хэвлэсэн 2016
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer

    Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer -н Weiguo Xiang, Lijie Zhao, Xin Han, Tianfeng Xu, Steven Kregel, Mi Wang, Bukeyan Miao, Chong Qin, Mingliang Wang, Donna McEachern, Jianfeng Lü, Longchuan Bai, Chao‐Yie Yang, Paul D. Kirchhoff, John Takyi‐Williams, Lu Wang, Bo Wen, Duxin Sun, Mark A. Ator, Robert McKean, Arul M. Chinnaiyan, Shaomeng Wang

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment

    Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment -н Amar Mirza, Micah A. Fry, N. Urman, Scott X. Atwood, Jon Roffey, Gregory R. Ott, Bin Chen, Alex Lee, Alexander S. Brown, Sumaira Z. Aasi, Tyler Hollmig, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Craig A. Zificsak, Marina Sirota, Jean Y. Tang, Atul J. Butte, Ervin H. Epstein, Kavita Y. Sarin, Anthony E. Oro

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and <i>In Vivo</i> Antitumor Activity

    CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and <i>In Vivo</i> Antitumor Activity -н Joyce James, Bruce Ruggeri, Robert C. Armstrong, Martin W. Rowbottom, Susan Jones‐Bolin, Ruwanthi N. Gunawardane, Paweł Dobrzański, Michael F. Gardner, Hugh Zhao, Merryl Cramer, Kathryn Hunter, Ronald R. Nepomuceno, Mangeng Cheng, Dana Gitnick, Mehran Yazdanian, Darren E. Insko, Mark A. Ator, Julius Apuy, Raffaella Faraoni, Bruce D. Dorsey, Michael Williams, Shripad S. Bhagwat, Mark W. Holladay

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: